UNSPSC 51172333: Sugammadex sodium

This classification denotes a protective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ERJ6X2MXV7. European Medicines Agency schedules Sugammadex sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32205. Sugammadex sodium generally arises in the molecular formula C72H104O48S8.8NA. The term 'sugammadex sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule sugammadex sodium under HS 29329985 and SITC 51569.

Sugammadex sodium bears US NLM identifiers UMLS ID C2350811 and NCI Concept Code C78123. SMILES: As of Q4 2014, SUGAMMADEX SODIUM remains US FDA's Preferred Term for this commodity.

UNSPSC 51172333 Sugammadex sodium is a Commodity code that, based on recent state and local solicitation activity, does not appear to reflect the pharmaceutical product its name denotes. Instead, the code captures drug-testing services and specimen analysis delivered through county criminal justice and community supervision systems. Collin County Community Supervision and Corrections Department posted RFP 2026-327 for offender specimen collection and drug testing services, with an estimated contract value of $600,000 and proposals due July 23, 2026. The scope includes staffing collection sites in Plano and McKinney during standard business hours plus five Saturdays annually, operating an Interactive Voice Response randomized-testing notification system, performing immunoassay screening with LC/MS/MS or GC/MS confirmation, electronic result reporting, and alternative methodologies including oral fluid and hair testing. Annual testing demand is approximately 25,031 tests comprising five-panel and six-panel screens with ancillary testing. Vendors must maintain lab certification from SAMHSA, Texas Department of Public Safety, or CAP, and pricing is structured on a per-test basis across three service models—screening only, confirmation after screening, and automatic confirmation of positives—with all costs inclusive of freight, delivery, insurance, and staffing and no additional surcharges permitted.

The single recent opportunity posted under this code originates from a Texas county agency. Collin County awarded the contract on a two-year term commencing September 1, 2026, with three optional one-year renewal periods, and evaluation weighted vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations worth up to 30 points. Funding derives from Texas Department of Criminal Justice Community Justice Assistance Division appropriations, subject to annual availability. The mismatch between the code's pharmaceutical name and the recent opportunity's focus on criminal-justice drug-testing logistics suggests this code may be misapplied in state and local procurement systems or reflects a data-entry error rather than a reliable indicator of current buying activity in sugammadex sodium or related pharmaceutical products.